Learn More About the 8th TIL Therapies Summit

The 8th TIL Therapies Summit brings together the companies, researchers, and clinical leaders driving the next generation of tumor-infiltrating lymphocyte therapies for solid tumors. Explore the articles below to gain insight into the latest advances in engineered TIL, gene editing, manufacturing innovation, potency and quality control frameworks, clinical development, and commercialization strategies, alongside the regulatory, operational, and scalability challenges shaping the field. These are the discussions helping determine how TIL therapies can expand patient access, improve outcomes across solid tumor indications, and evolve from promising clinical programs into commercially successful treatments.

Browse our selection of expert insights exploring the latest advances, challenges, and opportunities shaping the future of TIL therapies.

The Future of TIL Therapy Beyond Melanoma

Explore the opportunities and challenges of expanding TIL therapies beyond melanoma, and discover how developers are advancing engineered TILs, manufacturing innovation, and combination strategies to unlock success across solid tumors.

Screenshot 2026-09-04 114627

The Biggest Manufacturing Challenges Facing TIL Developers

Explore the manufacturing challenges impacting TIL development, and discover how developers are improving consistency, scalability, and turnaround times to support commercial success.

Hanson Wade Event Image

How Are Companies Improving TIL Persistence and Durability?

Explore the strategies being used to enhance TIL persistence and durability, and discover how developers are leveraging cell selection, gene editing, and combination approaches to drive long-term clinical responses.

Hanson Wade Event Image

What Can the Industry Learn from the First Approved TIL Therapies?

Explore the lessons emerging from the first approved TIL therapies, and discover how manufacturing readiness, treatment logistics, and commercial execution are shaping the future of the field.

Hanson Wade Event Image
Hanson Wade Event Image

Explore the Agenda

Hear the latest breakthroughs for KSQ, Obsidian, AgonOx, in TIL therapy and gain exclusive scientific insights during our packed agenda, interactive roundtables, and expert-led panel discussions.

Hanson Wade Event Image

Partner With Us

Position your brand alongside leading solution providers, the 8th TIL Therapies Summit is where you can position your company as the name in TIL therapy.

Hanson Wade Event Image

Join TIL Therapy Experts

Be part of the most important conversations in cell therapy, connecting with attendees spanning every stage of TIL development.